Camp4 Therapeutics (CAMP) Other Gross PP&E Adjustments (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly Other Gross PP&E Adjustments came in at $9.3 million in Q1 2026, up 96.07% year-on-year from $4.7 million in Q1 2025, and up 7.78% quarter-over-quarter from $8.6 million in Q4 2025.
Camp4 Therapeutics (CAMP) Other Gross PP&E Adjustments (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed Other Gross PP&E Adjustments across 4 years of filings, most recently posting $9.3 million for Q1 2026.
- Other Gross PP&E Adjustments for Q1 2026 came in at $9.3 million, up 96.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.3 million (up 96.07% YoY), and the FY2025 annual result was $8.6 million, up 111.49% from the prior year.
- Other Gross PP&E Adjustments came in at $9.3 million for Q1 2026 at Camp4 Therapeutics, up from $8.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.5 million in Q2 2025 to a low of $3.0 million in Q3 2024.
- The 4-year median for Other Gross PP&E Adjustments is $8.6 million (2023), against an average of $7.4 million.
- Across the five-year window, Other Gross PP&E Adjustments sank 52.37% in 2024 and surged 246.94% in 2025, its largest moves.
- Camp4 Therapeutics' Other Gross PP&E Adjustments stood at $8.6 million in 2023, then tumbled by 52.37% to $4.1 million in 2024, then jumped by 111.49% to $8.6 million in 2025, then climbed by 7.78% to $9.3 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at $9.3 million (Q1 2026), $8.6 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | 9.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.29 Mn |
| Mar 31, 2026 | 9.29 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Dec 31, 2023 | 8.55 Mn |
| Dec 31, 2023 | 8.55 Mn |